Skip to main content
logo
Edwards Lifesciences Corporation (EW)
NYSE: EW · Real-Time Price · USD
83.68
+0.64 (0.77%)
At close: Jul 28, 2026, 4:00 PM EDT
84.80
+1.12 (1.34%)
After-hours: Jul 28, 2026, 7:58 PM EDT

Edwards Lifesciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Quarter
Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021
Period Ending
Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21 Jun '21
Net Income
380.791.2290.3331.5356.4384.33,069365351369.7383.7305.5340.5398.4343.5406.4373.6335.3340.1489.5
Depreciation & Amortization
40.942.739.238.136.642.634.539.638.536.736.936.135.235.435.434.134.73333.635.8
Stock-Based Compensation
45.439.241.237.540.231.742.143.944.630.532.637.438.927.930.336.232.424.226.630.3
Other Adjustments
78.3-76.3-17.2-9.8-2.1-117.8-115.8-57.2-28.6-84.2-29.5-77.8-43.9-94-39.9-90.1-18-79.65-100.7
Change in Receivables
-117.932.413.2-24.9-43.7105.947.323-55-18.21.3-46.8-77.5-1.1-5.3-19.9-57.86.838-46.4
Changes in Inventories
-1.611-1.841.6-0.1-51.2-41.2-94.2-69.5-99.3-76-80.9-32.8-62.3-65.3-61.8-24-6.68.115
Changes in Accounts Payable
-347.1168.7226.1103.7-103.4-3.129.9151.8-89.133.436.4121.4-45.234.32627.5-109.231.179.394.1
Changes in Accrued Expenses
-50-14.8-12.5-12.5-36.7-12.5-12.5-6.6-5.2-7-11.5-43.829.3-8.9-16.4-9.7-10--22.82.1
Changes in Income Taxes Payable
41.957.6-10.2-240.451.2-488.5671.8-106.9-263.1-112.175.3-56.287.2-14.4-40.9-33.282.9335.89.1
Changes in Other Operating Activities
-26.8-8.9-22.1-9.2-18-22-11.77.922.9-12.9-37.7-21.1-17.6-32.5-12.64.5-11.36.414.2-2.7
Operating Cash Flow
43.8450.9573.7290.2280.4-127.5351.8371.5-53.5136.6411.533.6314.1282.8309.9332.2293.3373.6531.9526.1
Operating Cash Flow Growth (YoY)
-84.38%-63.08%-21.88%---14.51%1005.65%--51.70%32.78%-89.89%7.09%-24.30%-41.74%-36.86%-2.40%-6.55%146.14%127.45%

Investing Activities

Fiscal Quarter
Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021
Period Ending
Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21 Jun '21
Capital Expenditures
-64.9-97.4-57.5-49.3-56-49.8-51.9-85.4-65.3-88.3-55.3-47.9-61.5-68.9-59.9-43.1-72.7-89.8-60.7-69.3
Purchases of Intangible Assets
------4.6-5.40-2000-0.2-13.1-------
Purchases of Investments
-653.6-826.7-1,032-630.3-647.3-390.7-566.1-13.3-2.6-43.6-9.6-6.6-15.7-81-293.3-92.9-202.1-1,054-413.5-334.1
Proceeds from Sale of Investments
722.6714.5691.9626.1845.6268.1175.9247166.6137.4180.4134.1263.9273.5224359.6502197.1113.681.7
Cash Acquisitions
-35.1-----298.2---4600-141.2-------
Other Investing Activities
-61.8-52.5-29.9-70.3-57-74.1-14.6-23.5-15.6-21.6-26.5-9.2-31.9-8.7-72.3-942.3-14.9-16.8-2.1
Investing Cash Flow
-92.8-198.3-427.8-172.185.3-576.72,702124.863.114.18970.20.594.7-201.5129.6229.5-965.9-377.4-329.5

Financing Activities

Fiscal Quarter
Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021
Period Ending
Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21 Jun '21
Long-Term Debt Issued
-----------------0-8.89.5
Long-Term Debt Repaid
------------------0.18.7-10.7
Net Long-Term Debt Issued (Repaid)
------------------0.1-0.1-1.2
Issuance of Common Stock
68.932.334.757.249.928.634.554.362.133.23460.841.927.532.44937.533.938.954.2
Repurchase of Common Stock
-521.8-40.6-538.7-5.5-308.6-100.1-1,001-158.1-0.2-448.4-174.4-7.5-249.3-866-100.4-355.1-405.6-96.5-1.8-111.9
Net Common Stock Issued (Repurchased)
-452.9-8.3-50451.7-258.7-71.5-966.5-103.861.9-415.2-140.453.3-207.4-838.5-68-306.1-368.1-62.637.1-57.7
Other Financing Activities
1.7-3.1-2.410.70.1-10.27.2-0.22.3-2.9-1.20.80.2-1.9-1.9-0.72-0.1
Financing Cash Flow
-451.2-11.4-740.152.7-25828.6-976.7-96.661.7-413.2-143.352.1-206.6-838.4-69.9-308.1-368.1-6239-59

Net Cash Flow

Fiscal Quarter
Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021
Period Ending
Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21 Jun '21
Foreign Exchange Rate Adjustments
8.23.5-1-29.6-17.751-51.529.49.7-3.49.215.2-4.2-18.210.313.913.21.80.5-2.6
Net Cash Flow
-492244.7-595.2141.290-624.62,025429.181-265.9366.4171.1103.8-479.148.8167.6167.9-652.5194135

Free Cash Flow

Fiscal Quarter
Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021
Period Ending
Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21 Jun '21
Free Cash Flow
-21.1353.5516.2240.9224.4-177.3299.9286.1-118.848.3356.2-14.3252.6213.9250289.1220.6283.8471.2456.8
Free Cash Flow Growth (YoY)
--72.12%-15.80%---15.81%---77.42%42.48%-14.51%-24.63%-46.94%-36.71%13.42%-0.98%317.73%271.38%
FCF Margin
-1.28%22.52%33.24%15.72%15.88%-12.79%22.14%20.89%-8.93%3.81%28.65%-1.10%17.31%15.86%18.95%21.04%16.45%21.34%35.96%33.20%
Free Cash Flow Per Share
-0.040.610.880.410.38-0.300.500.47-0.200.080.58-0.020.410.350.400.460.350.450.750.73
Levered Free Cash Flow
-26.9250.1452.3205.2231.6-198.93,690272.5-78.9120.4353214.7335.1281.1209.8324.7264342.3397.5572.4
Unlevered Free Cash Flow
-11.47266.21418.85217.13204.43-308.04934.07253.61-125.3365.09284.25151.08326.39271.12205.67320.15266.31340.71397.08570.55
SEC Filings: 10-K · 10-Q